Evidence map›Paper›PMID 30146045›Full record

ReviewInternational review of neurobiology2018

Optimizing Placebo and Minimizing Nocebo to Reduce Pain, Catastrophizing, and Opioid Use: A Review of the Science and an Evidence-Informed Clinical Toolkit.

Beth D Darnall, Luana Colloca

3 registry-linked trialsOpen access · greenAbstract readReview
In one paragraph

Review in International review of neurobiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
16.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04491175 nacompletednot on this mapstarted 2022, after this paper: background citation

Addressing Opioid Use Disorder With an External Multimodal Neuromodulation Device: Development and Clinical Evaluation of DuoTherm for Opioid-Sparing Pain Relief in Acute and Chronic Low Back Pain

TypeinterventionalSponsorMMJ Labs LLCRan2022 to 2025Enrolled160ConditionsOpioid Use, Low Back PainArmsM-Stim, TENS
NCT04494698 nacompletednot on this mapstarted 2022, after this paper: background citation

Addressing Pain and Disability From Low Back Pain With an External Multimodal Neuromodulation Device

TypeinterventionalSponsorMMJ Labs LLCRan2022 to 2025Enrolled160ConditionsAcute Low-back Pain, Chronic Low-back Pain, Pain, IntractableArmsDuotherm VibraCool Back Device, TENS 8-channel unit
NCT04494841 nacompletednot on this mapstarted 2020, after this paper: background citation

Addressing Feasibility of the DuoTherm in Acute and Chronic Low Back Pain

TypeinterventionalSponsorMMJ Labs LLCRan2020 to 2021Enrolled20ConditionsLow Back Pain, Low Back Sprain, Low Back Pain, RecurrentArmsDuotherm VibraCool Back Device
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Brain circuits for pain and its treatment.Science translational medicine · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Beth D DarnallSchool of Medicine, Department of Anesthesiology, Perioperative and Pain Medicine, Division of Pain Medicine, Psychiatry and Behavioral Sciences (by courtesy), Stanford University, Palo Alto, CA, United States. Electronic address: bdarnall@stanford.edu.
Luana CollocaDepartment of Pain Translational Symptom Science, School of Nursing, University of Maryland, Baltimore, MD, United States; Departments of Anesthesiology and Psychiatry, School of Medicine, University of Maryland, Baltimore, MD, United States; Center to Advance Chronic Pain Research, University of Maryland, Baltimore, MD, United States.
Stanford Medicine · USUniversity of Maryland, Baltimore · US

Funding

Single Session Pain Catastrophizing Treatment: Comparative Efficacy & MechanismsR01AT008561 · NCCIH · STANFORD UNIVERSITY · PI DARNALL, BETH DENISE, MACKEY, SEAN C · 2015 to 2019
$3.9M
Chronic orofacial pain: genetics, cognitive-emotional factors, and endogenous modulatory systemsR01DE025946 · NIDCR · UNIVERSITY OF MARYLAND BALTIMORE · PI COLLOCA, LUANA · 2016 to 2019
$2.1M
NCCIH NIH HHS R01 AT008561NIDCR NIH HHS R01 DE025946
6 · The paper itself

Abstract

Pain, a noxious psychosensory experience, motivates escape behavior to assure protection and survival. Psychological factors alter the experience and trajectory of pain, as well as behavior and treatment response. In the context of pain, the placebo effect (expectation for pain relief) releases endogenous opioids and facilitates analgesia from exogenously administered opioids. Nocebo hyperalgesia (expectation for persistent or worsening pain) opposes endogenous opioid analgesia and patient engagement in prescription opioid tapering. Reductions in nocebo hyperalgesia and pain catastrophizing may enhance descending modulation of pain, mediate adaptive structural brain changes and promote patient engagement in opioid tapering. Interventions that minimize nocebo and optimize placebo may adaptively shape the central nervous system toward pain relief and potentially opioid reduction. Here we provide a critical description of catastrophizing and its impact on pain, placebo and nocebo effects. We also consider the importance of minimizing nocebo and optimizing placebo effects during prescription opioid tapering, and offer a clinical toolkit of resources to accomplish these goals clinically.

Indexed as

CatastrophizationNocebo EffectPlacebo EffectAnalgesics, OpioidHumansHyperalgesiaPainPain ManagementAnalgesics, OpioidCatastrophizingChronic painEvidence-basedExpectationsNoceboOpioidsPainPatient-centeredPlaceboTreatment

Identifiers

PMID30146045
PMCPMC6175287
OpenAlexW2885893311

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.